AbbVie Submits Supplemental New Drug Application to U.S. FDA to Support New Indication of LINZESS® (linaclotide) for Functional Constipation in Children and Adolescents 6 to 17 Years of Age ...Middle East

Hence then, the article about abbvie submits supplemental new drug application to u s fda to support new indication of linzess linaclotide for functional constipation in children and adolescents 6 to 17 years of age was published today ( Friday 16/12/2022 - 03:56 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( AbbVie Submits Supplemental New Drug Application to U.S. FDA to Support New Indication of LINZESS® (linaclotide) for Functional Constipation in Children and Adolescents 6 to 17 Years of Age )

Also on site :

• PIN Stockholder Alert: Shareholder Rights Law Firm Robbins LLP Reminds Investors of the Class Action Lawsuit Against Pinterest, Inc.
• The One Detail in 'Heated Rivalry' Star Connor Storrie’s Wild New Project Everyone’s Noticing
• The Strong Reaction Real-Life Doctors Have To The Pitt, According To Noah Wyle